Nav: Home

SIR 2016: Improving patient care through innovation, research and technology

January 22, 2016

Fairfax, Va. -- Registration is now open for the Society of Interventional Radiology's (SIR's) Annual Scientific Meeting, the world's most comprehensive interventional radiology meeting dedicated to improving patient care through research in image-guided, minimally invasive medicine. This year's meeting takes place April 2, 2016 through April 7, 2016 at the Vancouver Convention Centre in Vancouver, British Columbia.

Expected to attract more than 5,000 doctors, researchers and allied health professionals, SIR 2016 features more than 250 scientific presentations and 125 companies unveiling their latest IR medical devices, products and services. Attendees will be equipped with current data on breakthrough treatments for numerous diseases and conditions including stroke, cancer, uterine fibroids, and venous and peripheral arterial disease.

"Many of the IR procedures that we perform today were first introduced in the scientific sessions at past SIR annual meetings," said Brian Funaki, MD, FSIR, the meeting's scientific program chair. "During this year's meeting, we will present the most current critical information about clinical trials, technical innovations and the basic science at the foundation of our specialty."

In addition to learning about life-changing scientific findings and treatment innovations, this year's meeting will also offer the opportunity to collaborate with other disciplines through the "SIR Meets" gatherings, which feature multidisciplinary interactions with other specialties. Meanwhile, activities with international IR societies will explore innovation and lessons from around the world.

SIR 2016's general sessions feature the IR's top thought-leaders on major, often controversial, issues. This year's Dr. Charles T. Dotter Lecture, presented by Scott O. Trerotola, MD, FSIR, will explore how embracing competition can better IR patient care by spurring innovation.

"The ultimate goal of SIR 2016 is to provide inspiration and information about innovations that have the power to improve the care that interventional radiologists deliver," said Funaki, who is a professor of radiology and the vascular and interventional radiology section chief at the University of Chicago School of Medicine.

More information may be found at Early bird registration ends Jan. 29, 2016 and the advance registration deadline is Feb. 19. To register for the meeting, visit
About the Society of Interventional RadiologyThe Society of Interventional Radiology is a nonprofit, professional medical society representing more than 5,600 practicing interventional radiology physicians, scientists and clinical associates, dedicated to improving patient care through the limitless potential of image-guided therapies. SIR's members work in a variety of settings and at different professional levels--from medical students and residents to university faculty and private practice physicians. Visit

Society of Interventional Radiology

Related Clinical Trials Articles:

Review evaluates how AI could boost the success of clinical trials
In a review publishing July 17, 2019 in the journal Trends in Pharmacological Sciences, researchers examined how artificial intelligence (AI) could affect drug development in the coming decade.
Kidney patients are neglected in clinical trials
The exclusion of patients with kidney diseases from clinical trials remains an unsolved problem that hinders optimal care of these patients.
Clinical trials beginning for possible preeclampsia treatment
For over 20 years, a team of researchers at Lund University has worked on developing a drug against preeclampsia -- a serious disorder which annually affects around 9 million pregnant women worldwide and is one of the main causes of death in both mothers and unborn babies.
Underenrollment in clinical trials: Patients not the problem
The authors of the study published this month in the Journal of Clinical Oncology investigated why many cancer clinical trials fail to enroll enough patients.
When designing clinical trials for huntington's disease, first ask the experts
Progress in understanding the genetic mutation responsible for Huntington's disease (HD) and at least some molecular underpinnings of the disease has resulted in a new era of clinical testing of potential treatments.
New ALS therapy in clinical trials
New research led by Washington University School of Medicine in St.
Telemedicine helps improve participation in clinical trials
Videos and creative uses of other visuals provide a novel way to obtain informed consent during clinical trials to improve participants' understanding and retention of trial information, according to a study by Nemours Children's Health System presented at the American Thoracic Society (ATS) Annual Conference.
Not enough women included in some heart disease clinical trials
Women are underrepresented in clinical trials for heart failure, coronary artery disease and acute coronary syndrome but proportionately or overrepresented in trials for hypertension, atrial fibrillation and pulmonary arterial hypertension, when compared to incidence or prevalence of women within each disease population, according to a study in the Journal of the American College of Cardiology.
BU: Obese patients underrepresented in cancer clinical trials
A new review by Boston University School of Public Health researchers found that less than one-fifth of participants in cancer-related clinical trials are obese.
Are women really under-represented in clinical trials?
Several studies have reported a lack of gender diversity in clinical trials, with trials including mostly adult males; however, a recent review of publicly available registration data of clinical trials at the US Food and Drug Administration for the most frequently prescribed drug classes found no evidence of any systemic significant under-representation of women.
More Clinical Trials News and Clinical Trials Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at